BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
aarti drugs ltd. stock

AARTI DRUGS LTD. Share Price

445.15 -1.14 (-0.25%)
Dec 13 2024 03:30 PM Pharmaceuticals NSE: AARTIDRUGS

AARTI DRUGS LTD. Share Price Update

As of the latest trading session, AARTI DRUGS LTD. share price is currently at 445.15, which is down by -1.14 from its previous closing. Today, the stock has fluctuated between 437.95 and 447.80. Over the past year, AARTI DRUGS LTD. has achieved a return of -7.58 %. In the last month alone, the return has been -4.76 %. Read More...

AARTI DRUGS LTD. Performance

Day Range

Low437.95 High447.80
445.15

52 Week Range

Low 431.05 High 635.00
445.15

AARTI DRUGS LTD. Share Price

4481

524348

AARTIDRUGS

img img img img
No Data Available

Open Price

446.30

Prev. Close

446.30

Volume (Shares)

136230.00

Total traded value

606.42

Upper Circuit

535.55

Lower Circuit

357.05

Note: The current prices & values are delayed, Login to your account for live updates.

AARTI DRUGS LTD. Fundamentals


(Standalone)

Market Cap (Cr) 4092.48
PE Ratio (TTM) 32.72
Book Value / Share 126.17
Beta 0.59
ROE 12.39%
EPS (TTM) 13.60
Dividend Yield 0.22%
Net Profit Qtr (Cr) 30.39

AARTI DRUGS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 543.09
Operating Expense 502.58
Net Profit 30.39
Net Profit Margin (%) 5.59
Earnings Per Share (EPS) 3.33
EBITDA 59.92
Effective Tax Rate (%) 25.67
Particulars JUN 2024 (Values in Cr)
Revenue 492.96
Operating Expense 457.90
Net Profit 26.91
Net Profit Margin (%) 5.45
Earnings Per Share (EPS) 2.93
EBITDA 54.33
Effective Tax Rate (%) 23.46
Particulars MAR 2024 (Values in Cr)
Revenue 559.53
Operating Expense 510.90
Net Profit 36.14
Net Profit Margin (%) 6.45
Earnings Per Share (EPS) 3.93
EBITDA 70.17
Effective Tax Rate (%) 27.34
Particulars DEC 2023 (Values in Cr)
Revenue 538.21
Operating Expense 497.02
Net Profit 31.62
Net Profit Margin (%) 5.87
Earnings Per Share (EPS) 3.44
EBITDA 61.42
Effective Tax Rate (%) 26.24
Particulars SEP 2023 (Values in Cr)
Revenue 577.54
Operating Expense 531.44
Net Profit 34.58
Net Profit Margin (%) 5.98
Earnings Per Share (EPS) 3.75
EBITDA 66.16
Effective Tax Rate (%) 26.15
Particulars MAR 2024 (Values in Cr)
Revenue 2266.91
Operating Expense 2078.60
Net Profit 141.88
Net Profit Margin (%) 6.25
Earnings Per Share (EPS) 15.35
EBITDA 270.31
Effective Tax Rate (%) 26.28
Particulars MAR 2023 (Values in Cr)
Revenue 2497.97
Operating Expense 2295.39
Net Profit 152.81
Net Profit Margin (%) 6.11
Earnings Per Share (EPS) 16.50
EBITDA 284.63
Effective Tax Rate (%) 25.38
Particulars MAR 2022 (Values in Cr)
Revenue 2251.17
Operating Expense 2000.44
Net Profit 195.00
Net Profit Margin (%) 8.66
Earnings Per Share (EPS) 21.04
EBITDA 322.95
Effective Tax Rate (%) 23.67
Particulars MAR 2021 (Values in Cr)
Revenue 1914.89
Operating Expense 1583.82
Net Profit 257.71
Net Profit Margin (%) 13.45
Earnings Per Share (EPS) 27.65
EBITDA 407.92
Effective Tax Rate (%) 23.68
Particulars MAR 2020 (Values in Cr)
Revenue 1634.92
Operating Expense 1469.39
Net Profit 135.67
Net Profit Margin (%) 8.29
Earnings Per Share (EPS) 58.12
EBITDA 253.84
Effective Tax Rate (%) 22.46
Particulars MAR 2024 (Values in Cr)
Book Value / Share 139.40
ROE % 13.87
ROCE % 14.97
Total Debt to Total Equity 0.47
EBITDA Margin 12.85
Particulars MAR 2023 (Values in Cr)
Book Value / Share 128.77
ROE % 14.93
ROCE % 15.36
Total Debt to Total Equity 0.52
EBITDA Margin 11.47
Particulars MAR 2022 (Values in Cr)
Book Value / Share 111.92
ROE % 21.03
ROCE % 20.33
Total Debt to Total Equity 0.46
EBITDA Margin 13.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 98.01
ROE % 35.81
ROCE % 33.38
Total Debt to Total Equity 0.47
EBITDA Margin 20.66
Particulars MAR 2020 (Values in Cr)
Book Value / Share 280.04
ROE % 23.65
ROCE % 20.73
Total Debt to Total Equity 0.75
EBITDA Margin 15.03
Particulars MAR 2024 (Values in Cr)
Book Value / Share 127.83
ROE % 12.39
ROCE % 13.65
Total Debt to Total Equity 0.44
EBITDA Margin 12.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 120.34
ROE % 14.65
ROCE % 15.24
Total Debt to Total Equity 0.51
EBITDA Margin 11.54
Particulars MAR 2022 (Values in Cr)
Book Value / Share 104.99
ROE % 21.29
ROCE % 20.38
Total Debt to Total Equity 0.47
EBITDA Margin 14.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 92.23
ROE % 34.79
ROCE % 32.19
Total Debt to Total Equity 0.48
EBITDA Margin 21.46
Particulars MAR 2020 (Values in Cr)
Book Value / Share 266.86
ROE % 23.79
ROCE % 20.60
Total Debt to Total Equity 0.74
EBITDA Margin 15.74
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 9.43
Total Assets 2432.35
Total Liabilities 2432.35
Total Equity 1281.95
Share Outstanding 91935000
Price to Book Ratio 3.39
Return on Assets (%) 7.04
Return on Capital (%) 9.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 8.95
Total Assets 2421.39
Total Liabilities 2421.39
Total Equity 1192.66
Share Outstanding 92600000
Price to Book Ratio 2.81
Return on Assets (%) 6.86
Return on Capital (%) 9.24
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 22.33
Total Assets 2207.95
Total Liabilities 2207.95
Total Equity 1036.30
Share Outstanding 92600000
Price to Book Ratio 4.09
Return on Assets (%) 9.28
Return on Capital (%) 13.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 9.77
Total Assets 1766.01
Total Liabilities 1766.01
Total Equity 913.40
Share Outstanding 93200000
Price to Book Ratio 7.53
Return on Assets (%) 15.87
Return on Capital (%) 22.29
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.64
Total Assets 1576.50
Total Liabilities 1576.50
Total Equity 652.48
Share Outstanding 23300000
Price to Book Ratio 1.90
Return on Assets (%) 8.96
Return on Capital (%) 14.28
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 3.82
Total Assets 2171.61
Total Liabilities 2171.61
Total Equity 1175.20
Share Outstanding 91935000
Price to Book Ratio 3.39
Return on Assets (%) 6.53
Return on Capital (%) 8.61
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.67
Total Assets 2195.49
Total Liabilities 2195.49
Total Equity 1114.30
Share Outstanding 92600000
Price to Book Ratio 2.81
Return on Assets (%) 6.96
Return on Capital (%) 9.28
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.20
Total Assets 2034.52
Total Liabilities 2034.52
Total Equity 972.17
Share Outstanding 92600000
Price to Book Ratio 4.09
Return on Assets (%) 9.58
Return on Capital (%) 13.11
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 3.80
Total Assets 1637.00
Total Liabilities 1637.00
Total Equity 859.61
Share Outstanding 93200000
Price to Book Ratio 7.53
Return on Assets (%) 15.74
Return on Capital (%) 21.68
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.84
Total Assets 1470.69
Total Liabilities 1470.69
Total Equity 621.79
Share Outstanding 23300000
Price to Book Ratio 1.90
Return on Assets (%) 9.22
Return on Capital (%) 14.24
Particulars MAR 2024 (Values in Cr)
Net Income 235.52
Cash from Operations 421.32
Cash from Investing -223.65
Cash from Financing -136.03
Net change in Cash -0.76
Free Cash Flow 647.65
Particulars MAR 2023 (Values in Cr)
Net Income 224.18
Cash from Operations 192.99
Cash from Investing -163.97
Cash from Financing 16.54
Net change in Cash -14.10
Free Cash Flow 357.81
Particulars MAR 2022 (Values in Cr)
Net Income 269.95
Cash from Operations 153.79
Cash from Investing -149.63
Cash from Financing 92.02
Net change in Cash 12.79
Free Cash Flow 305.76
Particulars MAR 2021 (Values in Cr)
Net Income 369.01
Cash from Operations 251.62
Cash from Investing -71.77
Cash from Financing -81.12
Net change in Cash 2.04
Free Cash Flow 339.85
Particulars MAR 2020 (Values in Cr)
Net Income 185.28
Cash from Operations 291.61
Cash from Investing -33.20
Cash from Financing -215.40
Net change in Cash 2.12
Free Cash Flow 339.60
Particulars MAR 2024 (Values in Cr)
Net Income 192.48
Cash from Operations 388.33
Cash from Investing -187.09
Cash from Financing -148.80
Net change in Cash 1.20
Free Cash Flow 577.65
Particulars MAR 2023 (Values in Cr)
Net Income 204.81
Cash from Operations 216.52
Cash from Investing -131.13
Cash from Financing -30.53
Net change in Cash 0.02
Free Cash Flow 347.21
Particulars MAR 2022 (Values in Cr)
Net Income 255.49
Cash from Operations 119.98
Cash from Investing -125.35
Cash from Financing 84.11
Net change in Cash -1.35
Free Cash Flow 246.85
Particulars MAR 2021 (Values in Cr)
Net Income 337.71
Cash from Operations 241.95
Cash from Investing -69.03
Cash from Financing -85.27
Net change in Cash -0.13
Free Cash Flow 322.72
Particulars MAR 2020 (Values in Cr)
Net Income 174.97
Cash from Operations 233.46
Cash from Investing -29.35
Cash from Financing -167.75
Net change in Cash -0.96
Free Cash Flow 280.54
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 448.70
  • 26 Days 460.70
  • 10 Days 452.10
  • 50 Days 474.90
  • 12 Days 452.20
  • 100 Days 493.80
  • 20 Days 455.30
  • 200 Days 529.40
449.67
PIVOT
First Resistance 453.33
Second Resistance 460.37
Third Resistance 464.03
First Support 442.63
Second Support 438.97
Third Support 431.93
RSI 34.16
MACD -8.46
Commodity Channel Index (CCI) -191.22
ADX 45.71
Williams % R -77.43

Over 1 Month

down

-4.76

Over 3 Months

down

-15.20

Over 6 Months

down

-13.62

Over 1 Year

down

-7.58

Over 3 Years

down

-8.46

Over 5 Years

down

28.72

AARTI DRUGS LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

AARTI DRUGS LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
34.01
Promoter Holdings
55.64
FII
2.5
DII
7.83
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Prakash Moreshwar Patil Shareholding of Promoter and Promoter Group 8427413.0 9.23
Dsp Small Cap Fund Public Shareholding 5407942.0 5.93
Harshit Manilal Savla Shareholding of Promoter and Promoter Group 4323269.0 4.74
Rashesh Chandrakant Gogri Shareholding of Promoter and Promoter Group 4238874.0 4.64
Priti Prakash Patil Shareholding of Promoter and Promoter Group 4016315.0 4.4
Seema Harshit Savla Shareholding of Promoter and Promoter Group 3502175.0 3.84
Gogri Finserv Pvt. Ltd. Shareholding of Promoter and Promoter Group 3463971.0 3.8
Hetal Gogri Gala Shareholding of Promoter and Promoter Group 2787240.0 3.05
Harit Pragji Shah Public Shareholding 2436908.0 2.67
Anushakti Enterprise Private Limited Shareholding of Promoter and Promoter Group 2392696.0 2.62
Alchemie Finserv Pvt. Ltd. Shareholding of Promoter and Promoter Group 2013410.0 2.21
Chandrakant Vallabhaji Gogri Shareholding of Promoter and Promoter Group 1710097.0 1.87
Jayshree Harit Shah Public Shareholding 1634076.0 1.79
Jaya Chandrakant Gogri Shareholding of Promoter and Promoter Group 1564023.0 1.71
Aashyav Business Trust (alabhya Trusteeship Private Limited) Shareholding of Promoter and Promoter Group 1368429.0 1.5
Adhish P. Patil Shareholding of Promoter and Promoter Group 1132379.0 1.24
Blend Fund 2 Public Shareholding 1042449.0 1.14
Bhoomi Harshit Savla Shareholding of Promoter and Promoter Group 995164.0 1.09
Vishwa Harshit Savla Shareholding of Promoter and Promoter Group 939907.0 1.03
Tulip Family Trust (gloire Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 918806.0 1.01
Orchid Family Trust (relacion Trusteeship Services Private Limited) Shareholding of Promoter and Promoter Group 907077.0 0.99
Aashay Rashesh Gogri Shareholding of Promoter and Promoter Group 875891.0 0.96
Renil Rajendra Gogri Shareholding of Promoter and Promoter Group 731137.0 0.8
Mirik Rajendra Gogri Shareholding of Promoter and Promoter Group 731137.0 0.8
Paridhi Business Trust (saswat Trusteeship Private Limited) Shareholding of Promoter and Promoter Group 586471.0 0.64
Safechem Enterprises Private Limited Shareholding of Promoter and Promoter Group 558745.0 0.61
Dilesh Roadlines Pvt Ltd Shareholding of Promoter and Promoter Group 488730.0 0.54
Jigna Hiren Shah Shareholding of Promoter and Promoter Group 452597.0 0.5
Jay Manilal Savla Shareholding of Promoter and Promoter Group 252060.0 0.28
Indira Madan Dedhia Shareholding of Promoter and Promoter Group 193444.0 0.21
Aarnav Rashesh Gogri Shareholding of Promoter and Promoter Group 186365.0 0.2
Manisha Rashesh Gogri Shareholding of Promoter and Promoter Group 186763.0 0.2
Arati Tushar Sankhe Shareholding of Promoter and Promoter Group 172702.0 0.19
Prakash M. Patil (huf) (karta - Prakash Moreshwar Patil) Shareholding of Promoter and Promoter Group 161557.0 0.18
Arti Rajendra Gogri Shareholding of Promoter and Promoter Group 137781.0 0.15
Rajendra Vallabhaji Gogri Shareholding of Promoter and Promoter Group 101022.0 0.11
Arun Moreshwar Patil Shareholding of Promoter and Promoter Group 72864.0 0.08
Uday Moreshwar Patil Shareholding of Promoter and Promoter Group 50252.0 0.06
Alchemie Financial Services Limited Shareholding of Promoter and Promoter Group 38544.0 0.04
Vikas Moreshwar Patil Shareholding of Promoter and Promoter Group 34143.0 0.04
Kalika Amit Mishra Shareholding of Promoter and Promoter Group 25164.0 0.03
Kenisha Savla Shareholding of Promoter and Promoter Group 13817.0 0.02
Hriman Savla Shareholding of Promoter and Promoter Group 13817.0 0.02
Harshit M. Savla (huf) (karta - Harshit Manilal Savla) Shareholding of Promoter and Promoter Group 5866.0 0.01
Aarti Life Science Llp Shareholding of Promoter and Promoter Group 13369.0 0.01
Aarti Industries Limited Shareholding of Promoter and Promoter Group 0.0 0.0

AARTI DRUGS LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2024-02-06 1.0 Interim 2024-02-06 Equity shares 2023-02-08 1.0 Interim 2023-02-08 Equity shares 2022-02-09 1.0 Interim 2022-02-10 Equity shares 2020-11-03 2.5 Interim 2020-11-04 Equity shares 2020-02-17 2.0 Interim 2020-02-18 Equity shares 2019-07-26 1.0 Final 2019-07-30 Equity shares 2018-08-01 1.0 Final 2018-08-03 Equity shares 2017-08-09 1.0 Final 2017-08-11 Equity shares 2016-03-22 3.0 Interim 3 2016-03-24 Equity shares 2016-02-12 1.5 Interim 2 2016-02-15 Equity shares 2015-11-10 2.25 Interim 2015-11-14 Equity shares 2015-08-05 3.0 Final 2015-08-07 Equity shares 2015-02-04 5.0 Interim 2 2015-02-05 Equity shares 2014-11-19 5.0 Interim 1 2014-11-20 Equity shares 2014-07-02 5.5 Final 2014-07-04 Equity shares 2014-02-05 4.5 Interim 2 2014-02-06 Equity shares 2013-11-19 3.0 Interim 2013-11-14 Equity shares 2013-07-24 4.0 Final 2013-07-26 Equity shares 2013-02-11 3.0 Interim 2 2013-02-12 Equity shares 2012-11-05 3.0 Interim 2012-11-06 Equity shares 2012-08-17 3.0 Final 2012-08-22 Equity shares 2012-02-06 2.0 Interim 2012-02-07 Equity shares 2011-07-14 2.5 Final 2011-07-16 Equity shares 2011-02-07 2.5 Interim 2011-02-08 Equity shares 2010-08-18 5.0 Final 2010-08-21 Equity shares 2009-07-23 3.0 Final 2009-07-25 Equity shares 2008-08-13 1.8 Final 2008-08-16 Equity shares 2007-03-20 1.2 Final 2007-03-21 Equity shares 2005-07-27 0.0 Final 2005-07-29 Equity shares
Ex-Date Ex-Bonus Ratio
2020-10-01 2020-09-30 3:1 2015-03-25 2015-03-24 1:1 1996-06-11 1996-05-13 1:2
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About AARTI DRUGS LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by AARTI DRUGS LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Aarti Drugs Ltd?

Answer Field

The share price of Aarti Drugs Ltd for NSE is ₹ 445.15 and for BSE is ₹ 444.2.

What is the Market Cap of Aarti Drugs Ltd?

Answer Field

The market cap of Aarti Drugs Ltd for NSE is ₹ 40,92.48 Cr. and for BSE is ₹ 40,83.75 Cr. as of now.

What is the 52 Week High and Low of Aarti Drugs Ltd?

Answer Field

The 52 Week High and Low of Aarti Drugs Ltd for NSE is ₹ 635.00 and ₹ 431.05 and for BSE is ₹ 634.90 and ₹ 430.00.

How to Buy Aarti Drugs Ltd share?

Answer Field

You can trade in Aarti Drugs Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Aarti Drugs Ltd?

Answer Field

The 1 year returns on the stock has been -7.58%.

What is the Current Share Price of Aarti Drugs Ltd?

Answer Field

Aarti Drugs Ltd share price is for NSE ₹ 445.15 & for BSE ₹ 444.2 as on Dec 13 2024 03:30 PM.

What is the Market Cap of Aarti Drugs Ltd Share?

Answer Field

The market cap of Aarti Drugs Ltd for NSE ₹ 40,92.48 & for BSE ₹ 40,83.75 as on Dec 13 2024 03:30 PM.

What is the P/E Ratio of Aarti Drugs Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM the price-to-earnings (PE) ratio for Aarti Drugs Ltd share is 32.72.

What is the PB ratio of Aarti Drugs Ltd Share?

Answer Field

As on Dec 13 2024 03:30 PM, the price-to-book (PB) ratio for Aarti Drugs Ltd share is 126.17.

How to Buy Aarti Drugs Ltd Share?

Answer Field

You can trade in Aarti Drugs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aarti Drugs Ltd Share on Bajaj Broking App?

Answer Field

To buy Aarti Drugs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aarti Drugs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader